This protocol addresses patients with persistent allergic rhinitis — symptoms occurring more than four days per week and more than four weeks per year — whose nasal congestion, rhinorrhea, or nasal/ocular symptoms continue to affect quality of life despite initial treatment.
Persistent allergic rhinitis is defined as symptoms lasting more than four days per week and more than four weeks per year. When these symptoms significantly affect quality of life, a structured treatment approach is indicated. The clinical goal of this protocol is resolution of nasal congestion, rhinorrhea, and nasal/ocular symptoms.
This next-step protocol applies when allergen avoidance and patient education, combined with an intranasal corticosteroid alone, have not achieved adequate resolution of allergic rhinitis symptoms — including nasal congestion and ocular symptoms.
Intranasal corticosteroids typically require two to four weeks for maximum effectiveness. Escalation to this protocol is appropriate once that window has passed without sufficient relief.
The protocol considers targeted adjunctive options based on the predominant remaining complaint. For nasal congestion, for example, certain adjunctive interventions may be added — though specific safety considerations regarding duration of use apply. The complete selection criteria, sequencing, and full clinical approach for all symptom types are in the full protocol.
Frequency can be divided into intermittent or persistent (more than four days per week and more than four weeks per year, respectively).
The International Primary Care Respiratory Group; British Society for Allergy and Clinical Immunology; and American Academy of Allergy, Asthma, and Immunology recommend intranasal corticosteroids alone for the initial treatment of persistent symptoms affecting quality of life and second-generation nonsedating antihistamines for mild intermittent disease.
Consider adding nasal irrigation or a decongestant for nasal congestion, ipratropium (Atrovent) or intranasal antihistamine for rhinorrhea, or intranasal antihistamine for persistent nasal ocular symptoms.
Use of nasal decongestants for longer than three days is not recommended because of possible rebound congestion.
View source ↗